Van Eck Associates Corp Bio Rad Laboratories, Inc. Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 723,471 shares of BIO stock, worth $261 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
723,471
Previous 1,303,752
44.51%
Holding current value
$261 Million
Previous $437 Million
45.6%
% of portfolio
0.3%
Previous 0.55%
Shares
11 transactions
Others Institutions Holding BIO
# of Institutions
455Shares Held
17.7MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$688 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$560 Million0.01% of portfolio
-
Veritas Asset Management LLP1.09MShares$392 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$257 Million0.5% of portfolio
-
Select Equity Group, L.P. New York, NY708KShares$256 Million0.95% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.89B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...